
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.99 | 1.41 | 0.42 |
Shares | 98.60 | 98.60 | 0.00 |
Bonds | 0.02 | 0.02 | 0.00 |
Other | 0.39 | 0.39 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.19 | 19.62 |
Price to Book | 5.00 | 4.36 |
Price to Sales | 1.93 | 2.36 |
Price to Cash Flow | 19.55 | 15.71 |
Dividend Yield | 1.21 | 1.14 |
5 Years Earnings Growth | 15.13 | 11.11 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.89 | 99.58 |
Financial Services | 0.11 | 1.14 |
Number of long holdings: 149
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 9.61 | 363.66 | +1.36% | |
Eli Lilly | US5324571083 | 9.37 | 843.63 | -0.17% | |
Boston Scientific | US1011371077 | 6.37 | 95.90 | -0.83% | |
AbbVie | US00287Y1091 | 4.77 | 232.82 | +1.14% | |
Intuitive Surgical | US46120E6023 | 4.50 | 440.68 | -2.00% | |
Abbott Labs | US0028241000 | 3.50 | 133.00 | -0.55% | |
Danaher | US2358511028 | 3.31 | 208.77 | -1.39% | |
Stryker | US8636671013 | 2.97 | 369.24 | +0.81% | |
Amgen | US0311621009 | 2.86 | 295.54 | +0.48% | |
Thermo Fisher Scientific | US8835561023 | 2.85 | 539.17 | -0.88% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BlackRock S&P 500 Index K | 19.42B | 10.78 | 19.50 | 14.57 | ||
BlackRock International Index Instl | 12.96B | 23.15 | 17.40 | 7.49 | ||
BlackRock International Index Inv A | 12.96B | 22.93 | 17.08 | 7.21 | ||
BlackRock International Index K | 12.96B | 23.18 | 17.45 | 7.54 | ||
BlackRock Equity Dividend Instl | 10.5B | 14.67 | 13.27 | 11.16 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review